Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
11/1997
11/06/1997WO1997040679A1 Methods for delivering compounds into a cell
11/06/1997CA2252862A1 P1, p4-dithio-p2,p3-monochloromethylene 5', 5'''-diadenosine p1, p4-tetraphosphate as antithrombotic agent
11/06/1997CA2252762A1 Methods and compounds for curing diseases caused by mutations
11/06/1997CA2252617A1 Methods for delivering compounds into a cell
11/05/1997EP0804601A1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle
11/05/1997EP0804480A1 Purified thrombopoietin and method of making it
11/05/1997EP0804470A1 Thrombin inhibitors, the preparation thereof and the use thereof for therapeutical, prophylactic and diagnostic applications
11/05/1997EP0804469A1 Novel peptide
11/05/1997EP0804465A1 Novel elastase inhibitors
11/05/1997EP0804464A1 Aromatic heterocyclic derivatives as enzyme inhibitors
11/05/1997EP0804440A1 Tricyclic benzazepine vasopressin antagonists
11/05/1997EP0804438A1 Tricyclic benzazepine vasopressin antagonists
11/05/1997EP0804437A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USES THEREOF
11/05/1997EP0804431A1 GLYCOPROTEIN IIb/IIIa ANTAGONISTS
11/05/1997EP0804418A2 Platelet aggregation inhibitors
11/05/1997EP0804239A1 Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof
11/05/1997EP0804237A1 Humanized antibodies against leukocyte adhesion molecule vla-4
11/05/1997EP0804192A1 Pharmaceutical preparations for tumour necrosis factor (tnf) inhibition
11/05/1997EP0804154A1 Transmucosal delivery system
11/05/1997EP0683789B1 N-alkyl-2-substituted atp analogues
11/05/1997CN1164234A Pyrrolo £2,3-d| pyrimidines and their use
11/05/1997CN1164194A Remedy for diseases caused by IL-6 production
11/05/1997CN1163934A Protein with thrombocytopoietic factor active
11/05/1997CN1163933A Protein with thrombocytopoietic factor active
11/05/1997CN1163764A Chinese medicine preparation for treating hemorrhoid and fistula
11/04/1997US5684711 System, method, and computer program for at least partially automatically generating chemical compounds having desired properties
11/04/1997CA2083698C (+)-alpha-(2,3-dimethoxyphenyl)-1- [2-(4-fluorophenyl) ethyl]-4-piperidinemethanol
11/04/1997CA2025413C S-triazolo¬3,4-i|purine derivatives
10/1997
10/30/1997WO1997040158A1 Epimorphin antagonist and process for producing the same
10/30/1997WO1997040145A1 Inactivation resistant factor viii
10/30/1997WO1997040069A2 Secreted proteins and polynucleotides encoding them
10/30/1997WO1997040024A1 Pyrazinone thrombin inhibitors
10/30/1997WO1997039749A2 Method for the prevention and treatment of cachexia and anorexia
10/30/1997WO1997039748A1 Modulators of molecules with phosphotyrosine recognition units
10/30/1997CA2252964A1 Pyrazinone thrombin inhibitors
10/30/1997CA2252088A1 Secreted proteins and polynucleotides encoding them
10/29/1997EP0803254A1 Alcoholic solutions containing acetylsalicylic acid for percutaneous administration, their use in antithrombotic therapy and medicaments
10/29/1997EP0802985A1 Cell cycle regulated repressor and dna element
10/29/1997EP0802983A2 Expression of urokinase plasminogen activator inhibitors
10/29/1997EP0802916A1 Low molecular weight bicyclic thrombin inhibitors
10/29/1997EP0802902A1 Indole derivatives useful in the treatment of osteoporosis
10/29/1997EP0802800A2 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
10/29/1997EP0493380B1 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs
10/29/1997CN1163104A Medicinal preparation containing shikimic acid and its derivatives, and its use in preparing anti-thrombosis and analgesic medicine
10/28/1997US5681961 Arylsulphonamides, pharmaceutical compositions containing these compounds and processes for preparing them
10/28/1997US5681925 Trifunctional antithrombin and antiplatelet peptides
10/28/1997US5681844 Methionine sulfone and s-substituted cysteine sulfone derivatives as enzyme inhibitors
10/28/1997US5681841 Cyclic urea derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
10/28/1997US5681838 Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte-aggregation
10/28/1997US5681823 P1, P4 -dithio-P2 -P3 -monochloromethylene 5', 5'"-diadenosine P1, P4 -tetraphosphate as antithrombotic agent
10/28/1997US5681750 Process for preparing a C1-esterase inhibitor concentrate (C1-INH), and concentrate obtained, for therapeutic use
10/28/1997US5681746 Genetic engineering
10/28/1997US5681721 Bifunctional urokinase variants with improved fibrinolytic characteristics and thrombin inhibiting effect
10/25/1997CA2199920A1 Acetylsalicylic acid-containing alcoholic solutions for percutaneous employment, their use for antithrombotic therapy, and a pharmaceutical
10/23/1997WO1997039033A1 Purification of factor viii complex by immunoaffinity chromatography
10/23/1997WO1997039024A1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
10/23/1997WO1997039021A1 Targeted therapeutic or diagnostic agents and methods of making and using same
10/23/1997WO1997038986A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
10/23/1997WO1997038984A1 N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-one derivatives as factor xa inhibitors
10/23/1997WO1997038980A1 New carboxylic acid derivatives, their production and use
10/23/1997WO1997038966A2 Cytoprotective compounds
10/23/1997WO1997026862A3 Improved concentrated injection and infusion solutions for intravenous administration
10/23/1997WO1996034890A3 Inhibitors of fibrin cross-linking and/or transglutaminases
10/23/1997CA2251381A1 New carboxylic acid derivatives, their production and use
10/23/1997CA2241051A1 Targeted therapeutic or diagnostic agents and methods of making and using same
10/23/1997CA2219151A1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
10/22/1997EP0801654A1 N-SUBSTITUTED GLYCINE DERIVATIVES AS INHIBITORS OF FACTOR Xa
10/22/1997EP0801650A1 Fibrinogen receptor antagonists
10/22/1997EP0801574A1 Modulation of integrin-mediated signal transduction
10/22/1997EP0801572A2 Composition for inhibiting intimal hyperplasia using pdgf antagonists and heparin
10/22/1997EP0640080B1 Substituted indoles as angiotensin ii antagonists
10/22/1997CN1162977A Modified Factor VII
10/22/1997CN1162921A A storage stable water solution for infusion containing a thrombin inhibitor
10/22/1997CN1162457A Hemostatic powder
10/21/1997US5679700 Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents
10/21/1997US5679690 Solution consists of antithrombin argatroban, micelle forming agents such as cholic acid derivatives and one or more lipids
10/21/1997US5679680 α-substituted hydrazides having calpain inhibitory activity
10/21/1997US5679677 Cardiovascular disorders
10/21/1997US5679542 Antithrombosis agents
10/21/1997CA2015049C Pharmaceutically efficacious pteridine derivatives
10/16/1997WO1997038101A1 Scf analog compositions and methods
10/16/1997WO1997038009A1 Cyclic adhesion inhibitors
10/16/1997WO1997037975A1 Carboxylic acid derivatives with an aggregation-inhibiting action
10/16/1997WO1997037688A2 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity
10/16/1997WO1997037644A1 Treatment of a hemoglobinopathy
10/16/1997WO1997030178A3 Diagnosing trinucleotide repeat diseases and genes involved therein
10/16/1997DE19614534A1 Neue Carbonsäurederivate, ihre Herstellung und Verwendung New carboxylic acid derivatives, their preparation and use
10/16/1997DE19614204A1 Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Carboxylic acid derivatives, medicaments containing these compounds, their use and processes for their preparation
10/16/1997CA2650637A1 Pharmaceutical composition containing angiotensin ii antagonist
10/15/1997EP0801074A1 Isolation of peptides from green barley leaf extract and use of same to inhibit human platelet aggregation
10/15/1997EP0800827A1 Regulation of the reactivity of human blood platelets by administration of an extract of sea pine (pycnogenol TM)
10/15/1997EP0800516A1 FIBRINOGEN RECEPTOR ANTAGONISTS HAVING SUBSTITUTED (b)-AMINO ACID RESIDUES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
10/15/1997EP0800395A1 Fibrinogen receptor antagonists
10/15/1997EP0800389A1 Novel compounds
10/15/1997EP0598770B1 New pyrazine derivatives, their preparation and their use
10/15/1997CN1162339A Polysaccharides having high iduronic acid content
10/15/1997CN1161850A Styptic for gynaecology
10/14/1997US5677448 Sulfonamidocarboxamides
10/14/1997US5677297 Benzazepine-, benzoxazepine- and benzothiazepine-n-acetic acid derivatives, process for their preparation and pharmaceutical compositions containing them
10/14/1997US5677165 Anti-CD40 monoclonal antibodies capable of blocking B-cell activation
1 ... 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 ... 671